A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report
ConclusionCombination immunotherapy may be an attractive option for HPV-related small cell head and neck cancers resistant to other treatment modalities and thus warrants further evaluation.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Diabetes | Diabetes Mellitus | Endocrinology | Head and Neck Cancer | Hypothyroidism | Immunotherapy | Lung Cancer | Oropharyngeal Cancer | Pathology | Squamous Cell Carcinoma | Yervoy